Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JETRO BIOLINK FORUM 2006:Importance of Alliances Stressed
September 25, 2006
- NWE PRODUCTS
September 25, 2006
- BUSINESS NEWS IN BRIEF
September 25, 2006
- Sekisui Chemical to Acquire Daiichi Pure Chemicals
September 25, 2006
- Sawai to Reorganize Its Hansha by Region
September 25, 2006
- Daiichi Sankyo to Transfer All Shares of DRL to Fuji Film
September 25, 2006
- TOPICS Janssen-Cilag, Ortho Biotech Receive 2006 Prix Galien for Velcade
September 25, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 25, 2006
- Daiko to Focus on R&D Due to Difficulty in Making All Strengths Available
September 25, 2006
- Kobayashi Pharm. Announces 3-Pronged Management Strategy
September 25, 2006
- Many Doctors See Problems with GE Drugs: JMA
September 25, 2006
- PFSB to Draft GL for Registered Drug Sellers' Examination
September 25, 2006
- GENERIC NEWS IN BRIEF
September 25, 2006
- Zaditen Capsules Approved as Switch-OTC Drug
September 25, 2006
- TMRC Increasing Focus on Drug Discovery, Development: Dr Ekimoto
September 25, 2006
- Stomach Cancer Risk 10 Times Higher in H. pylori-Positive People
September 25, 2006
- SRI Int'l to Expand Business in Japan
September 25, 2006
- One in Five People Are Aware of Dysuria Symptoms: Pfizer Survey
September 25, 2006
- Bio Japan 2..6
September 25, 2006
- Shionogi, Nichia Celebrate 30th Anniversary of Nichia Pharmaceutical
September 25, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…